197 related articles for article (PubMed ID: 18528704)
1. Amalgamation of Chlamydia pneumoniae inclusions with lipid droplets in foam cells in human atherosclerotic plaque.
Bobryshev YV; Killingsworth MC; Tran D; Lord R
Virchows Arch; 2008 Jul; 453(1):69-77. PubMed ID: 18528704
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of liver X receptor-α in macrophages infected with Chlamydia pneumoniae in human atherosclerotic arteries in situ.
Bobryshev YV; Orekhov AN; Killingsworth MC; Lu J
J Innate Immun; 2011; 3(5):483-94. PubMed ID: 21625070
[TBL] [Abstract][Full Text] [Related]
3. Delivery of Chlamydia pneumoniae to the vessel wall aggravates atherosclerosis in LDLr-/- mice.
Hauer AD; de Vos P; Peterse N; ten Cate H; van Berkel TJ; Stassen FR; Kuiper J
Cardiovasc Res; 2006 Jan; 69(1):280-8. PubMed ID: 16112098
[TBL] [Abstract][Full Text] [Related]
4. Chlamydia pneumoniae in atherosclerotic carotid artery plaques: high prevalence among heavy smokers.
Dobrilovic N; Vadlamani L; Meyer M; Wright CB
Am Surg; 2001 Jun; 67(6):589-93. PubMed ID: 11409810
[TBL] [Abstract][Full Text] [Related]
5. A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide.
Kalayoglu MV; Byrne GI
Infect Immun; 1998 Nov; 66(11):5067-72. PubMed ID: 9784505
[TBL] [Abstract][Full Text] [Related]
6. Chlamydia pneumoniae-induced foam cell formation requires MyD88-dependent and -independent signaling and is reciprocally modulated by liver X receptor activation.
Chen S; Sorrentino R; Shimada K; Bulut Y; Doherty TM; Crother TR; Arditi M
J Immunol; 2008 Nov; 181(10):7186-93. PubMed ID: 18981140
[TBL] [Abstract][Full Text] [Related]
7. Chlamydia pneumoniae infection related atherosclerotic clinical variables on carotid stenosis.
Colpan ME; Attar A; Colpan A; Karahan C; Seckin S; Sargon MF; Egemen N
J Clin Neurosci; 2004 May; 11(4):389-94. PubMed ID: 15080954
[TBL] [Abstract][Full Text] [Related]
8. Atherosclerosis: lipid infiltration or Chlamydia pneumoniae infection?
Shor A
Circulation; 2002 Oct; 106(18):e135-6; disscussion e135-6. PubMed ID: 12403680
[No Abstract] [Full Text] [Related]
9. Characterization of low-density lipoprotein uptake by murine macrophages exposed to Chlamydia pneumoniae.
Kalayoglu MV; Miranpuri GS; Golenbock DT; Byrne GI
Microbes Infect; 1999 May; 1(6):409-18. PubMed ID: 10602673
[TBL] [Abstract][Full Text] [Related]
10. Chlamydia pneumoniae--induced macrophage foam cell formation is mediated by Toll-like receptor 2.
Cao F; Castrillo A; Tontonoz P; Re F; Byrne GI
Infect Immun; 2007 Feb; 75(2):753-9. PubMed ID: 17145941
[TBL] [Abstract][Full Text] [Related]
11. Chlamydophila pneumoniae and human cytomegalovirus in atherosclerotic carotid plaques--combined presence and possible interactions.
Virok D; Kis Z; Kari L; Barzo P; Sipka R; Burian K; Nelson DE; Jackel M; Kerenyi T; Bodosi M; Gönczol E; Endresz V
Acta Microbiol Immunol Hung; 2006 Mar; 53(1):35-50. PubMed ID: 16696549
[TBL] [Abstract][Full Text] [Related]
12. Carotid artery atherosclerotic plaque: clinical and morphological-immunohistochemical correlation.
Lastas A; Graziene V; Barkauskas E; Salkus G; Rimkevicius A
Med Sci Monit; 2004 Nov; 10(11):CR606-14. PubMed ID: 15507852
[TBL] [Abstract][Full Text] [Related]
13. Induction of macrophage foam cell formation by Chlamydia pneumoniae.
Kalayoglu MV; Byrne GI
J Infect Dis; 1998 Mar; 177(3):725-9. PubMed ID: 9498454
[TBL] [Abstract][Full Text] [Related]
14. Chlamydia pneumoniae does not influence atherosclerotic plaque behavior in patients with established carotid artery stenosis.
Gibbs RG; Sian M; Mitchell AW; Greenhalgh RM; Davies AH; Carey N
Stroke; 2000 Dec; 31(12):2930-5. PubMed ID: 11108751
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein levels and viable Chlamydia pneumoniae in carotid artery atherosclerosis.
Johnston SC; Messina LM; Browner WS; Lawton MT; Morris C; Dean D
Stroke; 2001 Dec; 32(12):2748-52. PubMed ID: 11739967
[TBL] [Abstract][Full Text] [Related]
16. Chlamydia pneumoniae induces macrophage-derived foam cell formation via PPAR alpha and PPAR gamma-dependent pathways.
Mei CL; He P; Cheng B; Liu W; Wang YF; Wan JJ
Cell Biol Int; 2009 Mar; 33(3):301-8. PubMed ID: 19114110
[TBL] [Abstract][Full Text] [Related]
17. Chlamydia pneumoniae in carotid artery atherosclerosis: a comparison of its presence in atherosclerotic plaque, healthy vessels, and circulating leukocytes from the same individuals.
Prager M; Türel Z; Speidl WS; Zorn G; Kaun C; Niessner A; Heinze G; Huk I; Maurer G; Huber K; Wojta J
Stroke; 2002 Dec; 33(12):2756-61. PubMed ID: 12468766
[TBL] [Abstract][Full Text] [Related]
18. Multiple genotypes of Chlamydia pneumoniae identified in human carotid plaque.
Cochrane M; Walker P; Gibbs H; Timms P
Microbiology (Reading); 2005 Jul; 151(Pt 7):2285-2290. PubMed ID: 16000718
[TBL] [Abstract][Full Text] [Related]
19. Signaling events in pathogen-induced macrophage foam cell formation.
Shaik-Dasthagirisaheb YB; Mekasha S; He X; Gibson FC; Ingalls RR
Pathog Dis; 2016 Aug; 74(6):. PubMed ID: 27481727
[TBL] [Abstract][Full Text] [Related]
20. The association of carotid plaque inflammation and Chlamydia pneumoniae infection with cerebrovascular symptomatology.
Kaperonis EA; Liapis CD; Kakisis JD; Perrea D; Kostakis AG; Karayannakos PE
J Vasc Surg; 2006 Dec; 44(6):1198-204. PubMed ID: 17145421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
